Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Kavanagh

Concepts (667)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
83
2024
344
11.950
 Why?
Radiation Oncology
28
2022
82
6.630
 Why?
Lung Neoplasms
62
2025
2526
4.040
 Why?
Prostatic Neoplasms
29
2020
1043
3.290
 Why?
Brain Neoplasms
36
2025
1238
3.160
 Why?
Carcinoma, Non-Small-Cell Lung
31
2025
1081
2.850
 Why?
Radiotherapy
17
2016
201
2.520
 Why?
Radiotherapy Planning, Computer-Assisted
32
2025
130
2.130
 Why?
Liver Neoplasms
21
2019
786
2.120
 Why?
Neoplasms
29
2025
2671
2.100
 Why?
Radiotherapy Dosage
46
2023
268
1.950
 Why?
Radiotherapy, Conformal
18
2017
70
1.940
 Why?
Radiation Injuries
16
2018
145
1.800
 Why?
Radiotherapy, Intensity-Modulated
16
2019
142
1.800
 Why?
Glioblastoma
13
2025
345
1.720
 Why?
Four-Dimensional Computed Tomography
9
2025
30
1.710
 Why?
Small Cell Lung Carcinoma
6
2023
96
1.560
 Why?
Cranial Irradiation
7
2020
70
1.430
 Why?
Brachytherapy
16
2016
121
1.360
 Why?
Chemoradiotherapy
10
2025
225
1.330
 Why?
Cone-Beam Computed Tomography
9
2023
39
1.300
 Why?
Dacarbazine
9
2016
98
1.240
 Why?
Antineoplastic Agents, Alkylating
7
2025
73
1.140
 Why?
Pulmonary Ventilation
5
2021
79
1.140
 Why?
Aged
103
2025
23961
1.080
 Why?
Humans
227
2025
137585
1.070
 Why?
Radiotherapy, Adjuvant
8
2015
220
1.030
 Why?
Societies, Medical
9
2021
820
1.010
 Why?
Aged, 80 and over
56
2025
7635
0.920
 Why?
Middle Aged
106
2025
33479
0.910
 Why?
Uterine Cervical Neoplasms
10
2016
257
0.880
 Why?
SEER Program
10
2018
227
0.850
 Why?
Astrocytoma
5
2025
128
0.800
 Why?
Radiation Oncologists
2
2022
5
0.800
 Why?
Neoplasm Metastasis
10
2020
658
0.790
 Why?
Radiation Pneumonitis
6
2021
29
0.770
 Why?
Male
116
2025
67762
0.770
 Why?
Radiometry
10
2022
50
0.760
 Why?
Neoplasm Recurrence, Local
14
2014
1079
0.740
 Why?
Dose-Response Relationship, Radiation
20
2021
141
0.740
 Why?
Neoplasm Staging
24
2018
1389
0.730
 Why?
Whole-Body Irradiation
4
2020
78
0.720
 Why?
Databases, Factual
10
2017
1357
0.710
 Why?
Registries
5
2018
2035
0.700
 Why?
Neoplasm Grading
6
2016
307
0.700
 Why?
Internship and Residency
5
2022
1147
0.700
 Why?
Social Media
2
2020
158
0.690
 Why?
Medicine
2
2021
121
0.660
 Why?
Videoconferencing
1
2020
66
0.660
 Why?
Liver
9
2018
1943
0.650
 Why?
Travel
1
2020
130
0.630
 Why?
Scattering, Radiation
5
2022
101
0.630
 Why?
United States
31
2022
14841
0.630
 Why?
ErbB Receptors
12
2025
614
0.630
 Why?
Radiation
1
2019
24
0.620
 Why?
Carcinoma, Squamous Cell
8
2007
683
0.610
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2009
152
0.610
 Why?
Models, Economic
1
2019
58
0.610
 Why?
Combined Modality Therapy
25
2019
1236
0.600
 Why?
Female
105
2025
73304
0.600
 Why?
Respiratory Function Tests
3
2023
600
0.600
 Why?
Insurance, Health, Reimbursement
1
2019
99
0.590
 Why?
Quality of Life
8
2025
2892
0.590
 Why?
Carcinoma, Renal Cell
5
2015
217
0.580
 Why?
Treatment Outcome
33
2025
10811
0.570
 Why?
Kidney Neoplasms
6
2015
403
0.570
 Why?
Antineoplastic Agents, Immunological
2
2019
190
0.560
 Why?
Adult
72
2025
37929
0.560
 Why?
Breast Neoplasms
11
2022
2253
0.560
 Why?
Lung
11
2024
4060
0.550
 Why?
Protein Kinase Inhibitors
7
2024
916
0.550
 Why?
Stereotaxic Techniques
3
2006
39
0.550
 Why?
Faculty, Medical
1
2020
283
0.540
 Why?
Prostate-Specific Antigen
8
2016
162
0.530
 Why?
Neoplasms, Second Primary
2
2008
118
0.510
 Why?
Preoperative Care
2
2018
362
0.510
 Why?
Antineoplastic Agents
13
2023
2129
0.510
 Why?
Prospective Studies
25
2025
7604
0.500
 Why?
Radiotherapy, Computer-Assisted
6
2015
12
0.500
 Why?
Insurance Coverage
4
2019
230
0.480
 Why?
Organs at Risk
5
2021
32
0.480
 Why?
Models, Biological
8
2018
1783
0.470
 Why?
Androgen Antagonists
6
2020
82
0.470
 Why?
Oligodendroglioma
1
2014
15
0.460
 Why?
Disease-Free Survival
12
2019
686
0.460
 Why?
Radiation Tolerance
7
2015
96
0.450
 Why?
Observational Studies as Topic
1
2015
117
0.440
 Why?
Health Physics
2
2016
5
0.440
 Why?
Immunologic Factors
1
2016
236
0.430
 Why?
Perfusion Imaging
1
2014
58
0.430
 Why?
Checklist
1
2015
93
0.430
 Why?
Beauty
1
2013
19
0.420
 Why?
Clinical Trials as Topic
9
2017
1050
0.420
 Why?
Magnetic Resonance Imaging
9
2023
3566
0.420
 Why?
Artifacts
4
2019
129
0.410
 Why?
Spiral Cone-Beam Computed Tomography
2
2023
5
0.410
 Why?
Phantoms, Imaging
5
2023
152
0.400
 Why?
Credentialing
1
2012
18
0.400
 Why?
Medicare
4
2021
773
0.390
 Why?
Liver Regeneration
2
2012
46
0.390
 Why?
Oxygen
5
2016
931
0.390
 Why?
Kaplan-Meier Estimate
11
2019
889
0.390
 Why?
Retrospective Studies
35
2024
15657
0.390
 Why?
Proton Therapy
2
2015
13
0.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
11
2019
1692
0.380
 Why?
Survival Analysis
11
2020
1325
0.380
 Why?
Antibodies
2
2018
410
0.370
 Why?
Hemoglobin A
2
2002
21
0.370
 Why?
Follow-Up Studies
18
2019
5131
0.360
 Why?
Lymph Nodes
1
2014
491
0.360
 Why?
Rectum
4
2014
185
0.350
 Why?
Relative Biological Effectiveness
2
2008
4
0.350
 Why?
Carcinoma
2
2006
240
0.350
 Why?
Survival Rate
13
2019
1972
0.350
 Why?
Patient Reported Outcome Measures
2
2025
402
0.340
 Why?
Consensus
4
2022
683
0.340
 Why?
Erlotinib Hydrochloride
4
2019
72
0.340
 Why?
Radiotherapy, High-Energy
2
2008
17
0.340
 Why?
Comparative Effectiveness Research
1
2011
152
0.330
 Why?
Skin Neoplasms
2
2015
855
0.320
 Why?
Stomach
1
2010
110
0.320
 Why?
Prognosis
15
2020
4030
0.320
 Why?
Proportional Hazards Models
9
2019
1266
0.310
 Why?
Positron-Emission Tomography
6
2019
294
0.310
 Why?
Radiation-Sensitizing Agents
4
2002
43
0.310
 Why?
Career Choice
2
2021
219
0.310
 Why?
Neoplastic Stem Cells
1
2013
399
0.310
 Why?
Cell Hypoxia
3
2002
226
0.300
 Why?
Antigens, Neoplasm
3
2009
319
0.300
 Why?
Intestine, Small
1
2010
156
0.300
 Why?
Antigens, CD
2
2009
521
0.300
 Why?
Receptor Protein-Tyrosine Kinases
4
2015
234
0.290
 Why?
Respiratory Mechanics
1
2008
67
0.290
 Why?
Quinazolines
6
2014
251
0.290
 Why?
Risk Assessment
4
2015
3457
0.280
 Why?
Vision, Ocular
1
2008
37
0.280
 Why?
Radiation Protection
2
2009
38
0.280
 Why?
Medical Oncology
3
2020
289
0.280
 Why?
Carcinoma, Transitional Cell
1
2008
71
0.270
 Why?
Orbit
1
2008
70
0.270
 Why?
Head and Neck Neoplasms
3
2008
606
0.270
 Why?
Spinal Neoplasms
2
2007
32
0.270
 Why?
Pyrazoles
4
2021
423
0.270
 Why?
Prostatectomy
3
2014
104
0.260
 Why?
Retroperitoneal Neoplasms
1
2007
25
0.260
 Why?
Pyridines
4
2021
506
0.260
 Why?
Linear Models
2
2010
849
0.260
 Why?
Adrenergic alpha-Antagonists
1
2006
36
0.260
 Why?
Bone Neoplasms
4
2019
247
0.260
 Why?
Aniline Compounds
3
2024
102
0.260
 Why?
Urologic Diseases
1
2006
41
0.260
 Why?
Glomus Jugulare Tumor
1
2006
5
0.250
 Why?
Patient Selection
3
2021
696
0.250
 Why?
Colorectal Neoplasms
4
2017
806
0.250
 Why?
Algorithms
7
2017
1704
0.250
 Why?
Histocompatibility Antigens Class I
1
2007
203
0.250
 Why?
Cancer Vaccines
1
2007
172
0.250
 Why?
Time Factors
9
2021
6828
0.240
 Why?
Tumor Burden
9
2014
309
0.240
 Why?
Melanoma
3
2018
760
0.240
 Why?
T-Lymphocytes, Regulatory
1
2008
385
0.230
 Why?
Necrosis
4
2022
246
0.230
 Why?
Central Nervous System
3
2023
258
0.230
 Why?
Pneumonia, Viral
2
2020
373
0.230
 Why?
Lymphocyte Activation
2
2009
1142
0.230
 Why?
Coronavirus Infections
2
2020
364
0.230
 Why?
Data Mining
2
2016
116
0.230
 Why?
Signal-To-Noise Ratio
3
2019
67
0.230
 Why?
CTLA-4 Antigen
3
2018
99
0.230
 Why?
Urinary Bladder Neoplasms
1
2008
252
0.230
 Why?
Insurance, Health
2
2018
283
0.230
 Why?
Practice Guidelines as Topic
5
2021
1587
0.230
 Why?
Particle Accelerators
3
2019
9
0.220
 Why?
Dendritic Cells
1
2007
483
0.220
 Why?
Tomography, X-Ray Computed
11
2015
2691
0.210
 Why?
Propionates
2
2001
39
0.210
 Why?
Virtual Reality
1
2025
61
0.210
 Why?
Immunotherapy, Adoptive
1
2007
327
0.210
 Why?
Chemotherapy, Adjuvant
7
2015
389
0.210
 Why?
Rectal Neoplasms
4
2008
149
0.210
 Why?
Pyrimidines
3
2024
470
0.200
 Why?
Oncogene Addiction
1
2023
5
0.200
 Why?
Carcinoma, Hepatocellular
1
2007
362
0.200
 Why?
Radiopharmaceuticals
3
2014
178
0.200
 Why?
Comprehension
1
2025
172
0.200
 Why?
Inappropriate ADH Syndrome
2
1993
8
0.200
 Why?
Nasopharyngeal Neoplasms
2
1993
21
0.200
 Why?
Molecular Targeted Therapy
2
2016
411
0.200
 Why?
Radiography
6
2014
822
0.200
 Why?
Carbon Dioxide
2
2002
267
0.190
 Why?
Propensity Score
4
2018
294
0.190
 Why?
Patient Education as Topic
3
2025
766
0.190
 Why?
Fluorodeoxyglucose F18
2
2013
135
0.190
 Why?
CD4-Positive T-Lymphocytes
1
2008
1091
0.190
 Why?
Analysis of Variance
4
2016
1316
0.180
 Why?
Protein-Tyrosine Kinases
2
2023
434
0.180
 Why?
Pelvis
3
2023
102
0.180
 Why?
Pandemics
2
2020
1639
0.180
 Why?
Proto-Oncogene Proteins c-ret
1
2021
36
0.180
 Why?
Imaging, Three-Dimensional
1
2025
580
0.170
 Why?
National Cancer Institute (U.S.)
2
2017
49
0.170
 Why?
Gene Rearrangement
3
2018
150
0.170
 Why?
Erythropoietin
1
2001
95
0.170
 Why?
Lymphatic Metastasis
3
2019
352
0.170
 Why?
Palatal Neoplasms
1
2000
7
0.170
 Why?
Technology, Radiologic
2
2010
6
0.170
 Why?
Radiographic Image Enhancement
1
2000
58
0.160
 Why?
Evidence-Based Medicine
2
2019
740
0.160
 Why?
Anemia
1
2001
170
0.160
 Why?
Proto-Oncogene Proteins
2
2023
648
0.160
 Why?
Electromagnetic Phenomena
1
2019
22
0.160
 Why?
Suggestion
1
2019
2
0.160
 Why?
Relative Value Scales
1
2019
5
0.160
 Why?
Pelvic Neoplasms
1
1999
26
0.160
 Why?
Fluoroscopy
1
2000
154
0.160
 Why?
Thoracic Neoplasms
3
2015
37
0.160
 Why?
Consolidation Chemotherapy
1
2019
10
0.160
 Why?
Erythrocyte Transfusion
1
2001
194
0.160
 Why?
Mass Screening
1
2008
1287
0.160
 Why?
Clinical Coding
1
2019
26
0.160
 Why?
Radiography, Interventional
1
2000
116
0.160
 Why?
Patient Care Planning
1
2000
157
0.150
 Why?
Positron Emission Tomography Computed Tomography
1
2020
98
0.150
 Why?
Adenocarcinoma
4
2008
940
0.150
 Why?
Epidermal Growth Factor
2
1998
177
0.150
 Why?
Piperidines
3
2024
206
0.150
 Why?
Genital Neoplasms, Female
1
2000
90
0.150
 Why?
Cell Survival
5
2008
1120
0.150
 Why?
Cohort Studies
4
2018
5742
0.150
 Why?
Image Processing, Computer-Assisted
3
2019
752
0.150
 Why?
Glioma
3
2010
395
0.150
 Why?
Radiobiology
4
2008
6
0.150
 Why?
Intensive Care Units
2
2007
827
0.150
 Why?
Farms
1
2018
5
0.150
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1998
182
0.150
 Why?
Aquaporin 4
1
2019
94
0.150
 Why?
Karnofsky Performance Status
3
2015
38
0.140
 Why?
Policy
1
2019
150
0.140
 Why?
Organ Size
3
2018
477
0.140
 Why?
Health Knowledge, Attitudes, Practice
1
2006
1329
0.140
 Why?
Industry
1
2018
68
0.140
 Why?
Radiographic Image Interpretation, Computer-Assisted
2
2015
110
0.140
 Why?
Frontal Lobe
1
1998
149
0.140
 Why?
Respiration, Artificial
1
2002
645
0.140
 Why?
Urinary Bladder
2
2010
183
0.140
 Why?
Cell Division
2
1997
794
0.140
 Why?
Multivariate Analysis
3
2019
1509
0.140
 Why?
Health Planning
1
2017
47
0.140
 Why?
Health Priorities
1
2017
44
0.140
 Why?
Immunity, Cellular
1
2019
268
0.140
 Why?
Maximum Tolerated Dose
4
2010
199
0.130
 Why?
Postoperative Care
2
2017
261
0.130
 Why?
Thymus Neoplasms
1
2017
25
0.130
 Why?
Thymoma
1
2017
36
0.130
 Why?
Risk Factors
7
2016
10388
0.130
 Why?
Vascular Resistance
1
2018
375
0.130
 Why?
Consensus Development Conferences, NIH as Topic
1
2016
2
0.130
 Why?
Cause of Death
2
2017
434
0.130
 Why?
Flunarizine
2
1993
2
0.130
 Why?
Preoperative Period
1
2017
129
0.130
 Why?
Perioperative Care
1
2018
178
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2018
249
0.120
 Why?
Surveys and Questionnaires
4
2025
5778
0.120
 Why?
Monitoring, Intraoperative
1
2016
56
0.120
 Why?
Pulmonary Atelectasis
1
2015
15
0.120
 Why?
Disease Progression
7
2019
2757
0.120
 Why?
Health Expenditures
1
2017
189
0.120
 Why?
Ventricular Function, Right
1
2018
285
0.120
 Why?
Oximetry
1
2016
96
0.120
 Why?
Gastrointestinal Tract
1
2018
195
0.120
 Why?
Salvage Therapy
4
2017
142
0.120
 Why?
Neurosurgery
1
2015
39
0.120
 Why?
Precision Medicine
2
2017
429
0.120
 Why?
Stroke Volume
1
2018
612
0.110
 Why?
Drug Administration Schedule
3
2014
786
0.110
 Why?
Vaginal Neoplasms
1
1994
18
0.110
 Why?
Induction Chemotherapy
2
2013
76
0.110
 Why?
Perineum
1
1994
32
0.110
 Why?
Multimodal Imaging
2
2013
113
0.110
 Why?
Health Services Research
1
2017
404
0.110
 Why?
Ventricular Function, Left
1
2018
534
0.110
 Why?
Marital Status
1
2014
44
0.110
 Why?
Maytansine
1
2014
16
0.110
 Why?
Technetium Tc 99m Pentetate
1
2014
7
0.110
 Why?
Ventilation-Perfusion Ratio
1
2014
10
0.110
 Why?
Quality Control
5
2013
172
0.110
 Why?
Nuclear Medicine
1
2014
9
0.110
 Why?
Soft Tissue Neoplasms
1
2015
115
0.110
 Why?
Risk
3
2016
912
0.110
 Why?
Sensitivity and Specificity
5
2016
1946
0.110
 Why?
Clinical Competence
2
2022
1118
0.110
 Why?
Prostate
1
2015
175
0.110
 Why?
Brain Edema
1
2014
61
0.110
 Why?
Adaptation, Physiological
1
2018
553
0.110
 Why?
Radiotherapy Setup Errors
1
2013
3
0.110
 Why?
Takayasu Arteritis
1
1994
16
0.110
 Why?
Cerebrovascular Circulation
1
2016
243
0.110
 Why?
Lymphoma, Large-Cell, Anaplastic
1
2014
20
0.110
 Why?
Incidence
3
2016
2804
0.110
 Why?
Xerostomia
1
1993
17
0.100
 Why?
Blood Viscosity
1
1993
17
0.100
 Why?
Oropharyngeal Neoplasms
1
1994
63
0.100
 Why?
Observer Variation
1
2014
343
0.100
 Why?
Health Care Reform
1
2014
107
0.100
 Why?
Lactates
1
1993
85
0.100
 Why?
Heart Ventricles
1
2018
788
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2019
1396
0.100
 Why?
Calcium
2
1998
1199
0.100
 Why?
Health Status Disparities
1
2016
289
0.100
 Why?
Randomized Controlled Trials as Topic
2
2015
1477
0.100
 Why?
Clinical Decision-Making
1
2015
322
0.100
 Why?
Erythrocytes
2
2001
700
0.100
 Why?
Young Adult
10
2025
13209
0.100
 Why?
Motion
2
2011
99
0.090
 Why?
Partial Pressure
2
2002
30
0.090
 Why?
Age Factors
2
2021
3295
0.090
 Why?
Physicians
1
2020
910
0.090
 Why?
Organ Specificity
2
2021
305
0.090
 Why?
Hepatic Veins
1
2011
33
0.090
 Why?
Oxytocin
1
1992
51
0.090
 Why?
Eponyms
1
1991
2
0.090
 Why?
Healthcare Disparities
1
2018
654
0.090
 Why?
Radiology
1
2014
180
0.090
 Why?
Remission Induction
3
2008
288
0.090
 Why?
Colorado
5
2015
4565
0.090
 Why?
Biomedical Research
1
2017
692
0.090
 Why?
Early Detection of Cancer
1
2016
447
0.090
 Why?
Radiation Dosage
4
2019
179
0.090
 Why?
Keratin-18
1
2010
10
0.090
 Why?
Esophagectomy
1
1992
131
0.080
 Why?
Burkitt Lymphoma
1
1991
60
0.080
 Why?
Computer Simulation
3
2012
978
0.080
 Why?
Esophageal Neoplasms
2
2008
321
0.080
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
123
0.080
 Why?
Carbazoles
2
2024
83
0.080
 Why?
Cardiac Surgical Procedures
1
2016
530
0.080
 Why?
Automation
2
2020
95
0.080
 Why?
Delphi Technique
2
2022
280
0.080
 Why?
Neoplasm, Residual
1
2010
133
0.080
 Why?
Respiration
2
2023
199
0.080
 Why?
Mutation
4
2025
3958
0.080
 Why?
Neoplasms, Multiple Primary
1
2010
57
0.080
 Why?
Meningeal Neoplasms
2
2021
100
0.080
 Why?
Risk Management
2
2020
93
0.080
 Why?
Immobilization
2
2010
43
0.080
 Why?
Caspase 3
1
2010
246
0.080
 Why?
Anthracyclines
1
2009
42
0.080
 Why?
History, 20th Century
2
2006
325
0.080
 Why?
Thoracic Wall
1
2009
18
0.080
 Why?
Catheter Ablation
1
2012
350
0.080
 Why?
Rib Fractures
1
2009
32
0.080
 Why?
Chest Pain
1
2009
91
0.070
 Why?
Neuroblastoma
1
2010
160
0.070
 Why?
Antibodies, Monoclonal, Humanized
1
2014
804
0.070
 Why?
DNA Repair
2
2008
231
0.070
 Why?
Antibiotics, Antineoplastic
1
2009
127
0.070
 Why?
Sex Factors
1
2014
2071
0.070
 Why?
Cross-Priming
1
2008
15
0.070
 Why?
Pharyngeal Neoplasms
1
2007
5
0.070
 Why?
Lymphocyte Count
1
2008
148
0.070
 Why?
Carcinoembryonic Antigen
1
2008
39
0.070
 Why?
Bile Duct Diseases
1
2008
14
0.070
 Why?
Carcinoma, Merkel Cell
1
2008
17
0.070
 Why?
Ki-67 Antigen
1
2008
112
0.070
 Why?
Treatment Failure
4
2014
356
0.070
 Why?
Statistics, Nonparametric
2
2018
431
0.070
 Why?
Malaria Vaccines
1
2007
8
0.070
 Why?
Feasibility Studies
4
2016
956
0.070
 Why?
Hemocyanins
1
2007
62
0.070
 Why?
Cholestasis, Intrahepatic
1
2008
39
0.070
 Why?
Photons
1
2008
70
0.070
 Why?
Laryngeal Neoplasms
1
2007
39
0.070
 Why?
Bile Ducts, Intrahepatic
1
2008
78
0.070
 Why?
T-Lymphocytes, Cytotoxic
1
2008
173
0.070
 Why?
CD8-Positive T-Lymphocytes
3
2009
900
0.070
 Why?
Fluorouracil
1
2008
208
0.070
 Why?
Accreditation
2
2022
83
0.070
 Why?
Deoxycytidine
1
2008
179
0.070
 Why?
Adolescent
7
2025
21513
0.070
 Why?
Pulmonary Disease, Chronic Obstructive
1
2015
1040
0.070
 Why?
Mouth Neoplasms
1
2007
120
0.060
 Why?
Quality Assurance, Health Care
1
2009
322
0.060
 Why?
Software
1
2012
665
0.060
 Why?
Cell Line, Tumor
3
2010
3412
0.060
 Why?
Pancreatic Neoplasms
1
2014
938
0.060
 Why?
Antigen Presentation
1
2007
218
0.060
 Why?
Severity of Illness Index
3
2007
2828
0.060
 Why?
Adjuvants, Immunologic
1
2007
226
0.060
 Why?
Postoperative Nausea and Vomiting
1
2006
16
0.060
 Why?
Urinary Tract
1
2006
51
0.060
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2008
336
0.060
 Why?
Whole Body Imaging
1
2006
25
0.060
 Why?
Oligopeptides
1
2008
271
0.060
 Why?
Hodgkin Disease
1
2008
138
0.060
 Why?
Intestines
1
2009
357
0.060
 Why?
Vertigo
1
2006
39
0.060
 Why?
Heart Diseases
1
2009
346
0.060
 Why?
Cranial Nerve Diseases
1
2006
42
0.060
 Why?
Physics
4
2010
17
0.060
 Why?
Delirium
1
2007
92
0.060
 Why?
Heart
2
2020
655
0.060
 Why?
DNA Damage
1
2008
420
0.060
 Why?
Reproducibility of Results
4
2016
3284
0.060
 Why?
History, 21st Century
1
2006
213
0.060
 Why?
X-linked Nuclear Protein
1
2025
9
0.060
 Why?
Cisplatin
2
2011
320
0.060
 Why?
DNA Modification Methylases
1
2025
17
0.060
 Why?
DNA Repair Enzymes
1
2025
28
0.060
 Why?
Light
1
2008
381
0.060
 Why?
Pilot Projects
3
2001
1710
0.060
 Why?
Isocitrate Dehydrogenase
1
2025
59
0.060
 Why?
Medical Records
3
2010
177
0.060
 Why?
Kidney
2
2010
1468
0.060
 Why?
Receptor, ErbB-2
2
2019
341
0.060
 Why?
Bevacizumab
2
2015
138
0.050
 Why?
Brain
3
2022
2668
0.050
 Why?
Cell Proliferation
2
2010
2475
0.050
 Why?
Interferon-gamma
1
2007
789
0.050
 Why?
Acrylamides
1
2024
57
0.050
 Why?
Immunotherapy
1
2009
641
0.050
 Why?
Body Burden
1
2003
8
0.050
 Why?
Maximum Allowable Concentration
1
2003
16
0.050
 Why?
Cell Count
2
1995
324
0.050
 Why?
Costs and Cost Analysis
2
2001
213
0.050
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
250
0.050
 Why?
Abdomen
1
2023
125
0.050
 Why?
Pentoxifylline
1
2002
25
0.050
 Why?
G2 Phase
1
2002
38
0.050
 Why?
Tumor Suppressor Proteins
1
2025
327
0.050
 Why?
Telomerase
1
2025
250
0.050
 Why?
Forecasting
2
2017
389
0.050
 Why?
Vasopressins
2
1993
64
0.050
 Why?
Acid-Base Equilibrium
1
2002
28
0.050
 Why?
Electrodes
1
2022
114
0.050
 Why?
Pulmonary Gas Exchange
1
2002
121
0.050
 Why?
Parotid Gland
1
2001
23
0.050
 Why?
Certification
2
2015
113
0.050
 Why?
Comorbidity
2
2017
1622
0.050
 Why?
Antibodies, Monoclonal
1
2009
1430
0.050
 Why?
Peptides
1
2007
985
0.050
 Why?
Proto-Oncogene Proteins c-raf
2
1998
45
0.050
 Why?
Research Design
2
2018
1139
0.040
 Why?
Tumor Cells, Cultured
3
2002
955
0.040
 Why?
Mastectomy
1
2022
137
0.040
 Why?
Oxygen Consumption
2
2016
696
0.040
 Why?
Apoptosis
1
2010
2553
0.040
 Why?
Indoles
1
2024
412
0.040
 Why?
Hepatitis B
1
2001
70
0.040
 Why?
Carboplatin
2
2011
144
0.040
 Why?
Probability
1
2001
304
0.040
 Why?
Skull Neoplasms
1
2000
23
0.040
 Why?
Rats
3
2002
5647
0.040
 Why?
Camptothecin
2
2011
116
0.040
 Why?
Alveolar Process
1
2000
6
0.040
 Why?
Oxygen Inhalation Therapy
1
2002
157
0.040
 Why?
Promoter Regions, Genetic
1
2025
1250
0.040
 Why?
Maxilla
1
2000
38
0.040
 Why?
Hospitals, Community
1
2000
52
0.040
 Why?
Palate
1
2000
38
0.040
 Why?
Patient Positioning
1
2020
67
0.040
 Why?
DNA Methylation
1
2025
643
0.040
 Why?
Mouth Mucosa
1
2000
92
0.040
 Why?
Canada
1
2021
418
0.040
 Why?
Enzyme Activation
2
1998
810
0.040
 Why?
Meningioma
1
2000
91
0.040
 Why?
APACHE
1
1999
69
0.040
 Why?
Lung Injury
1
2002
219
0.040
 Why?
Fibrosarcoma
1
1999
22
0.040
 Why?
Practice Patterns, Physicians'
1
2008
1313
0.040
 Why?
Ontario
1
1999
148
0.040
 Why?
Lymphopenia
1
2019
62
0.040
 Why?
Europe
1
2020
414
0.040
 Why?
Dexamethasone
2
2012
368
0.040
 Why?
Health Care Rationing
1
1999
59
0.040
 Why?
Workflow
1
2020
165
0.040
 Why?
Length of Stay
2
2007
1215
0.040
 Why?
Reoperation
2
2012
573
0.040
 Why?
Neutropenia
1
2019
146
0.040
 Why?
Leukocyte Count
1
2019
329
0.040
 Why?
Egtazic Acid
1
1998
40
0.040
 Why?
Hepatitis C
1
2001
271
0.040
 Why?
Tetradecanoylphorbol Acetate
1
1998
150
0.040
 Why?
Safety
1
2000
338
0.040
 Why?
Cell Line
2
2008
2847
0.040
 Why?
Triage
1
2020
222
0.040
 Why?
Immune System
1
2019
177
0.040
 Why?
Fatal Outcome
1
1998
303
0.040
 Why?
Tyrphostins
1
1997
18
0.040
 Why?
Neurosurgeons
1
2017
19
0.030
 Why?
Headache
1
1998
147
0.030
 Why?
Education, Medical, Graduate
1
2022
486
0.030
 Why?
Patient Admission
1
1999
197
0.030
 Why?
Academic Medical Centers
1
2000
512
0.030
 Why?
Medicaid
1
2021
435
0.030
 Why?
Caregivers
1
2025
877
0.030
 Why?
Betacoronavirus
1
2020
270
0.030
 Why?
Lymphocytes
1
2019
397
0.030
 Why?
Protein Kinase C
1
1998
261
0.030
 Why?
Syndrome
2
2008
358
0.030
 Why?
Program Evaluation
1
2021
898
0.030
 Why?
Movement
2
2010
278
0.030
 Why?
Biopsy
1
2000
1129
0.030
 Why?
Curriculum
1
2022
992
0.030
 Why?
National Institutes of Health (U.S.)
1
2016
128
0.030
 Why?
Rats, Inbred F344
2
1993
265
0.030
 Why?
Neurosurgical Procedures
1
2017
197
0.030
 Why?
Abdominal Neoplasms
1
2015
39
0.030
 Why?
Causality
1
2016
126
0.030
 Why?
Contrast Media
1
1998
467
0.030
 Why?
Medically Uninsured
1
2016
130
0.030
 Why?
Ions
1
2015
70
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2016
161
0.030
 Why?
Echocardiography
1
2018
642
0.030
 Why?
Age Distribution
1
2016
392
0.030
 Why?
Seizures
1
1998
426
0.030
 Why?
Sulfones
1
2015
110
0.030
 Why?
Myocardium
1
2020
1002
0.030
 Why?
Netherlands
1
2014
88
0.030
 Why?
Communication
1
2020
879
0.030
 Why?
North Carolina
1
2014
110
0.030
 Why?
Sigmoid Neoplasms
1
1994
5
0.030
 Why?
Trastuzumab
1
2014
96
0.030
 Why?
Models, Theoretical
1
2018
578
0.030
 Why?
Doxorubicin
2
2008
362
0.030
 Why?
Vital Capacity
1
2015
311
0.030
 Why?
Postoperative Complications
1
2006
2654
0.030
 Why?
Texas
1
2014
244
0.030
 Why?
Spatial Analysis
1
2013
20
0.030
 Why?
Models, Statistical
1
2018
669
0.030
 Why?
Forced Expiratory Volume
1
2015
531
0.030
 Why?
Neutrophils
1
2019
1238
0.030
 Why?
Monte Carlo Method
1
2013
148
0.030
 Why?
Erythrocyte Deformability
1
1993
19
0.030
 Why?
Animals
6
2010
36940
0.030
 Why?
Critical Illness
1
1999
811
0.030
 Why?
Choice Behavior
1
2014
170
0.030
 Why?
Socioeconomic Factors
1
2017
1289
0.020
 Why?
Rheology
1
1993
92
0.020
 Why?
Cell Cycle
1
1995
601
0.020
 Why?
Fiducial Markers
1
2012
9
0.020
 Why?
Regression Analysis
1
2015
1024
0.020
 Why?
Medical Errors
1
2013
112
0.020
 Why?
Hospital Information Systems
1
1992
16
0.020
 Why?
Neurophysins
1
1992
5
0.020
 Why?
Mammary Neoplasms, Experimental
1
1992
68
0.020
 Why?
Blood Transfusion, Autologous
1
1992
17
0.020
 Why?
Arginine Vasopressin
1
1992
44
0.020
 Why?
Nucleic Acid Hybridization
1
1992
190
0.020
 Why?
Hydrogen-Ion Concentration
1
1993
560
0.020
 Why?
DNA, Neoplasm
1
1992
164
0.020
 Why?
Lactic Acid
1
1993
305
0.020
 Why?
Protein Precursors
1
1992
134
0.020
 Why?
Diagnosis, Differential
1
2015
1483
0.020
 Why?
Etoposide
1
2011
158
0.020
 Why?
Africa
1
1991
108
0.020
 Why?
Patient Participation
1
2014
420
0.020
 Why?
Genomics
1
2016
795
0.020
 Why?
Cells, Cultured
2
2002
4193
0.020
 Why?
Longitudinal Studies
1
2018
2844
0.020
 Why?
X-Linked Inhibitor of Apoptosis Protein
1
2010
12
0.020
 Why?
Child
3
2025
21935
0.020
 Why?
Fibrosis
1
2013
552
0.020
 Why?
Retreatment
1
2010
72
0.020
 Why?
Amino Acid Chloromethyl Ketones
1
2010
25
0.020
 Why?
Carmustine
1
2010
50
0.020
 Why?
Cysteine Proteinase Inhibitors
1
2010
49
0.020
 Why?
In Situ Nick-End Labeling
1
2010
124
0.020
 Why?
Case-Control Studies
1
2018
3556
0.020
 Why?
Paclitaxel
1
2011
230
0.020
 Why?
Vincristine
1
2010
116
0.020
 Why?
Caspase Inhibitors
1
2010
81
0.020
 Why?
United Kingdom
1
1991
318
0.020
 Why?
Immunoblotting
1
2010
308
0.020
 Why?
Physical Phenomena
2
1999
13
0.020
 Why?
Palliative Care
2
2012
758
0.020
 Why?
Kinetics
1
1993
1670
0.020
 Why?
Lymphatic Irradiation
1
2009
10
0.020
 Why?
Urination Disorders
1
2009
13
0.020
 Why?
Cystitis
1
2009
22
0.020
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2010
233
0.020
 Why?
Hepatic Veno-Occlusive Disease
1
2008
14
0.020
 Why?
Logistic Models
1
2014
2074
0.020
 Why?
Ipilimumab
1
2009
33
0.020
 Why?
Nephrectomy
1
2010
169
0.020
 Why?
Prostheses and Implants
1
2010
143
0.020
 Why?
Neuropsychological Tests
1
2013
1023
0.020
 Why?
RNA Interference
1
2010
469
0.020
 Why?
Capecitabine
1
2008
45
0.020
 Why?
Premedication
1
2008
44
0.020
 Why?
Anti-Inflammatory Agents
1
2012
496
0.020
 Why?
Models, Animal
1
2010
384
0.020
 Why?
Administration, Oral
1
2010
816
0.020
 Why?
Mental Status Schedule
1
2007
33
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2010
852
0.020
 Why?
Antimetabolites, Antineoplastic
1
2008
94
0.020
 Why?
Smoking
1
2015
1627
0.020
 Why?
Cyclophosphamide
1
2008
247
0.020
 Why?
Blotting, Western
1
2010
1226
0.020
 Why?
Forearm
1
2008
119
0.020
 Why?
Quebec
1
2007
11
0.020
 Why?
Hemodynamics
1
1992
1113
0.020
 Why?
Prednisone
1
2008
240
0.020
 Why?
Diarrhea
1
2008
184
0.020
 Why?
Medical Audit
1
2007
78
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2007
76
0.020
 Why?
Medical History Taking
1
2007
117
0.020
 Why?
Pain Measurement
1
2009
521
0.020
 Why?
HIV Infections
1
2001
2836
0.020
 Why?
Tomography, Spiral Computed
1
2006
32
0.020
 Why?
Infant, Newborn
1
2018
6079
0.020
 Why?
Referral and Consultation
1
1992
786
0.020
 Why?
Tumor Suppressor Protein p53
1
2010
528
0.020
 Why?
Glucocorticoids
1
2010
594
0.020
 Why?
Pedigree
1
2007
514
0.020
 Why?
Epitopes
1
2008
479
0.020
 Why?
Guideline Adherence
1
2010
556
0.010
 Why?
Cognition
1
2013
1153
0.010
 Why?
Antiemetics
1
2005
43
0.010
 Why?
Spinal Cord Neoplasms
1
2004
37
0.010
 Why?
Amino Acid Sequence
1
2008
2139
0.010
 Why?
Molecular Sequence Data
1
2008
2900
0.010
 Why?
Esthetics
1
2003
51
0.010
 Why?
Testosterone
1
2007
409
0.010
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2003
56
0.010
 Why?
Mastectomy, Segmental
1
2003
93
0.010
 Why?
Carcinoma, Lobular
1
2003
49
0.010
 Why?
Radiation-Protective Agents
1
2002
26
0.010
 Why?
Carcinoma, Ductal, Breast
1
2003
83
0.010
 Why?
Spinal Cord
1
2005
370
0.010
 Why?
Disease Models, Animal
1
1993
4295
0.010
 Why?
Hospital Mortality
1
2007
911
0.010
 Why?
Cricetulus
1
2002
109
0.010
 Why?
Spheroids, Cellular
1
2002
76
0.010
 Why?
Signal Transduction
2
2010
5079
0.010
 Why?
Cricetinae
1
2002
289
0.010
 Why?
Craniotomy
1
2000
77
0.010
 Why?
Iridium Radioisotopes
1
1999
4
0.010
 Why?
Transplantation, Autologous
1
2000
238
0.010
 Why?
Skull
1
2000
139
0.010
 Why?
Cobalt Radioisotopes
1
1999
7
0.010
 Why?
Antisickling Agents
1
1999
8
0.010
 Why?
Surgical Flaps
1
2000
130
0.010
 Why?
Tumor Stem Cell Assay
1
1999
34
0.010
 Why?
Oxyhemoglobins
1
1999
23
0.010
 Why?
Allosteric Regulation
1
1999
97
0.010
 Why?
Neoplasm Invasiveness
1
2000
510
0.010
 Why?
Flow Cytometry
1
2002
1178
0.010
 Why?
Mice, Inbred C3H
1
1999
269
0.010
 Why?
Inositol 1,4,5-Trisphosphate
1
1997
21
0.010
 Why?
Phosphotyrosine
1
1997
39
0.010
 Why?
Phospholipase C gamma
1
1997
29
0.010
 Why?
Type C Phospholipases
1
1997
74
0.010
 Why?
Radiation, Ionizing
1
1997
80
0.010
 Why?
Pulmonary Circulation
1
1999
429
0.010
 Why?
Isoenzymes
1
1997
304
0.010
 Why?
Nitriles
1
1997
172
0.010
 Why?
Hemoglobins
1
1999
353
0.010
 Why?
Bronchial Neoplasms
1
1995
15
0.010
 Why?
Enzyme Inhibitors
1
1997
840
0.010
 Why?
Endometrial Neoplasms
1
1995
201
0.010
 Why?
Child, Preschool
1
2008
11074
0.010
 Why?
Postoperative Period
1
1994
342
0.010
 Why?
Intraoperative Period
1
1992
59
0.010
 Why?
Neoplasm Transplantation
1
1992
257
0.010
 Why?
Microcirculation
1
1992
149
0.010
 Why?
Orthopedics
1
1992
144
0.000
 Why?
Mice
1
1999
17787
0.000
 Why?
Kavanagh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (667) concept(s)
_
Co-Authors Expand Description
See all (55) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)